Pro Medicus (ASX:PME) reported Thursday that its earnings per diluted share in the fiscal first half rose to AU$0.4944 from AU$0.3461 per diluted share a year earlier.
Analysts polled by Visible Alpha were expecting EPS of AU$0.4957.
Revenue from contracts with customers for the six months to Dec. 31, 2024, was AU$97.2 million, up from AU$74.1 million in the same period a year earlier. Total revenue rose to AU$100.8 million from AU$76.3 million. Analysts surveyed by Visible Alpha expected total revenue of AU$99.7 million.
The board declared an interim dividend of AU$0.25 per share, up from the AU$0.18 per share in the previous reported period, payable on March 21 to shareholders on record as of Feb. 28.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。